Driada Medical HGH Fragment 176-191 5mg
Driada Medical HGH Fragment 176-191 5mg is a synthetic peptide representing the precise C-terminal portion of human growth hormone (amino acids 176-191), engineered to deliver maximum fat–burning efficacy without the systemic complications of full-length HGH. This fragment isolates the lipolytic properties of growth hormone while eliminating effects on blood glucose, insulin sensitivity, and cell proliferation. Clinical research confirms HGH Fragment 176–191 is up to 12.5 times more potent than standard HGH for fat oxidation, making it the premier choice for targeted adipose tissue reduction. The 5mg vial provides substantial material for extended fat-loss protocols, offering a safer alternative to complete growth hormone administration for individuals prioritizing body composition over structural growth.
Key Features
- Contains 5mg of synthetic HGH Fragment 176–191 (C-terminal amino acids 176-191)
- Isolated lipolytic fragment delivering 12.5x greater fat-burning potency than full HGH
- Stimulates lipolysis (fat breakdown) while inhibiting lipogenesis (fat creation)
- Zero impact on blood glucose levels, insulin sensitivity, or glucose tolerance
- Does not elevate IGF–1 levels or promote cell proliferation
- Avoids negative effects on carbohydrate metabolism associated with complete HGH
- Increases energy levels without structural growth or organ enlargement risks
- More suitable for obesity treatment and fat loss than standard human growth hormone
- Manufactured by Driada Medical under strict pharmaceutical quality standards
Where to Buy
- Available through specialized peptide distributors and verified research suppliers
- Purchase only from sources providing holographic security seals and batch verification
- Verify authenticity via the official Driada Medical portal before administration
- Request Certificate of Analysis (COA) to confirm peptide sequence purity and sterility
- Avoid unregulated markets containing mislabeled or degraded products
Product Specifications
- Active Ingredient: HGH Fragment 176-191
- Concentration: 5mg per vial (lyophilized powder)
- Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Form: Lyophilized powder requiring reconstitution with sterile water
- Storage: Store lyophilized at 2-8°C; reconstituted solution stable 14-30 days refrigerated
- Administration: Subcutaneous injection into adipose tissue
- Half-life: Approximately 10-20 minutes (requires multiple daily doses)
- Detection Time: Research chemical; prohibited by WADA for competitive sports
Mechanism of Action
HGH Fragment 176-191 mimics the natural fat-regulating mechanism of growth hormone without activating other GH receptor pathways. It binds to adipocyte membranes, triggering lipolysis through hormone-sensitive lipase activation. Simultaneously, it inhibits lipogenesis by blocking fatty acid synthase activity, preventing new fat storage. Unlike complete HGH, this fragment does not interact with liver receptors to stimulate IGF-1 production, avoiding impacts on cell proliferation and glucose metabolism. The peptide specifically targets visceral and subcutaneous adipose tissue, increasing lipolytic action directly at fat cell sites without systemic hormonal disruption.
Metabolic Impact
The administration creates targeted metabolic shifts in adipose tissue. It accelerates triglyceride breakdown and fatty acid release into circulation for energy utilization. The inhibition of lipogenesis prevents dietary calories from being stored as new fat, creating a net negative fat balance even in caloric maintenance. Users experience reduced body fat percentage without water retention, organ growth, or insulin resistance common with full HGH protocols. Energy levels increase through enhanced fatty acid oxidation, supporting sustained physical activity without carbohydrate dependency. The metabolic profile remains stable with no alterations to fasting glucose or insulin response.
Conclusion
Driada Medical HGH Fragment 176-191 5mg delivers the most concentrated fat-loss technology available in peptide form. Its ability to exceed HGH’s lipolytic potency by 12.5 times while avoiding metabolic side effects makes it superior for body composition goals. The 5mg dosage provides cost-effective material for intensive fat-reduction cycles without the risks of complete growth hormone administration.
Safety Warning
HGH Fragment 176-191 may cause injection site irritation, mild fatigue, or hypoglycemia in sensitive individuals. Long-term human safety data is limited. This product is not for recreational use. Consult a licensed physician before administration. Do not use if pregnant, nursing, or under 21 years old. This information is provided for educational purposes only. Actually using this product without medical supervision is illegal in many jurisdictions and could land you in serious legal trouble.




Reviews
There are no reviews yet.